Edwards Lifesciences Corp. announced that a federal jury in Boston returned a verdict in favor of CardiAQ in a lawsuit filed against a former service provider, Neovasc.

A new technique for cardiac magnetic resonance (CMR) imaging improves accuracy by removing patients' need to breathe, reveals research presented at EuroCMR 2016.

cardiac rehab, cardiac rehabilitation, CHF, heart failure

Cardiac rehabilitation and exercise training has been shown to improve clinical status and outcomes in congestive heart failure (CHF) patients.[1] However, it is often difficult to get patients to engage with rehabilitation, exercise and lifestyle changes. Sinai-Grace Hospital (SGH) in Detroit offers the following patient case study to illustrate how rehabilitation programs can aid CHF patients who are willing to engage with them to improve their health.

First-in-human data presented at EuroPCR 2016 demonstrate that hemodynamic data from HeartFlow Inc. may help predict which coronary plaques have the potential to rupture.

Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for two catheters that can be used with the Rhythmia Mapping System.

Mitralign Inc. announced it has raised $39.8 million to date in a Series E equity round of financing.

May 23, 2016 — In a guideline update published last week, the American College of Cardiology, American Heart Association and Heart Failure Society of America detail the groups’ recommendations for the use of two new heart failure medications.

Patients with a combination of left ventricular dysfunction and low aortic valve gradient have higher mortality rates and a greater risk of recurrent heart failure after transcatheter aortic valve replacement (TAVR).

Direct Flow Medical Inc. presented three-year results from its prospective, multicenter DISCOVER Trial at the EuroPCR meeting in Paris.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now